Galatea Bio

Galatea Bio designs and executes projects leveraging human genetic diversity for biomedical problem-solving. The company offers clinical testing services through a CLIA-CMS certified molecular diagnostics laboratory and biobank infrastructure. They partner with life sciences organizations to build large-scale population sequencing programs utilizing an extensive genomic-phenotypic data lake.

Traction 10/10

Miami Lakes, United States · HQ

Founded 2021391K+ followers

Artificial Intelligence
Biotechnology
Digital Health

Updated 7 months ago

Funding

Raised to date

$25.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Carlos Bustamante

CEO/founder

Saeid Akhtari

Founder/Managing Director

Product

Problem

Current precision health initiatives often lack comprehensive genetic testing and biobanking solutions, particularly for diverse populations, which limits the scope and applicability of biomedical research. Existing solutions may not adequately address participant privacy concerns, hindering participation and data availability.

Solution

Galatea Bio offers end-to-end genomic services and a large-scale genomic-phenotypic data lake designed to advance precision health for all populations. The company operates a CLIA-certified and CAP-accredited next-generation sequencing (NGS) molecular diagnostics clinical laboratory and biobank. Galatea Bio partners with pharmaceutical and life sciences organizations, academic universities, and health systems to build large-scale population sequencing programs. Their platform leverages a private genomic-phenotypic data lake and AI algorithms to solve problems in biomedicine while respecting research participant integrity, autonomy, and privacy.

Target Audience

Galatea Bio serves academic and private organizations, pharmaceutical and life sciences companies, academic universities, health systems, and physicians seeking comprehensive genetic testing and biobanking solutions.

Features

Full-stack infrastructure with a next-generation sequencing (NGS) molecular diagnostics clinical laboratory
CLIA-certified and CAP-accredited high-complexity lab
Large-scale population sequencing program consortiums
Proprietary genomic-phenotypic data lake
AI and algorithms for advanced biomedical research
Disease registries for epidemiological and genomics investigations
Biospecimen storage partnerships